Made by
Vibha bajpai
 Malaria

is a mosquito-borne infectious
disease of humans and other animals
caused by parasitic protozoans (a type of
unicellular microorganism) of the
genus Plasmodium
 the disease is transmitted via a bite from
an infected female Anopheles mosquito.
 which introduces the organisms from its
saliva into a person's circulatory system. In
the blood.
 Five

species of Plasmodium can infect and
be transmitted by humans.
 The vast majority of deaths are caused
by P. falciparum
 P. vivax
 P. ovale
 P. malariae
 P. knowlesi
 The

signs and symptoms of malaria typically
begin 8–25 days following infection.
 however, symptoms may occur later in those
who have taken antimalarial medications as
prevention.
 Initial manifestations of the disease—common
to all malaria species—are similar to flu-like
symptoms, and can resemble other conditions
such as septicemia, gastroenteritis, and viral
diseases.
 The
presentation
may
include headache, fever, shivering, joint
pain,
vomiting,
hemolytic
anemia,
jaundice,
hemoglobin
in
the
urine,retinal damage, and convulsions.
 The

classic
symptom
of
malaria
is paroxysm a cyclical occurrence of
sudden coldness followed by shivering and
then fever and sweating, occurring every
two
days
(tertian
fever)
in P. vivax and P. ovale infections, and
every three days (quartan fever)
forP. malariae. P. falciparum infection can
cause recurrent fever every 36–48 hours
or a less pronounced and almost
continuous fever.
respiratory distress
 metabolic acidosis
 pulmonary oedema,
 anaemia.
 , acute respiratory distress syndrome
 Infection with P. falciparum may result
in cerebral malaria

The life cycle of malaria parasites. A mosquito causes
infection by taking a blood meal.
 First, sporozoites enter the bloodstream, and migrate
to the liver.
 They infect liver cells, where they multiply into
merozoites, rupture the liver cells, and return to the
bloodstream.
 Then, the merozoites infect red blood cells, where they
develop into ring forms, trophozoites and schizonts
that in turn produce further merozoites.
 Sexual forms are also produced, which, if taken up by
a mosquito, will infect the insect and continue the life
cycle

 To

prevent and treat clinical attack of malaria
 To completely eradicate the parasite from the
patient body
 To reduce the human reservoir of infection
 Stage of plasmodium in liver called tissue
schizontocides…( pre+ exo
 - erythcytes.)
 stage of plasmodium in blood is called
gametocides.
 Chloroquine

 Amodiaquine

primaquine
sulfadoxine

artemether

halofantrine
 Piperaquine
sulfamethopyrazine
 Mefloquine
dapsone
atovaquone
 Quinine,quinidine tetracycline
 proguanil,
doxycycline
 Pyrimathaqunine artesunate
 1)Causal

prophylaxis: the
preerythrocytics phase in liver
 Proguanil, primaquine.
 2)Suppressive prophylaxis: the
exoerythrocytics phase in case of vivax
and other relapsing malaria continues,
clinical disease not appear.
 Chloroquine,proguanil,mefloquine,doxy
cycline
 3)

clinical cure: the erythrocytic,
schizontocides are used to terminate an
episode of disease.
 Fast acitng drug: chloroquine,
mefloquine, amodiaquine, quine,
halofantrine, atovaquone, artemisinin
 Slow acting drug:
proguanil,pyrimathamine, sulfonamides,
tetracycline.
 4)Radical

cure: in this attack the
exoerythrocytic stage( hypnozoites) to
achieved total eradication of parasite from
patient body. Drug primaquine
 Adequate for relapsing malaria.
 5) gametocidal: this refer to elimination of
the male and female gametes of plasmodia
from patient blood (reduce the transmission
to mosquito.
 Artesunate:

2.4 mg /kg iv or im after 12 to
24 hour.for 7 days
 Artemether: 3.2mg/kg on 1st day…then 1.6
mg/kg daily for 7 days
 Arteether: 3.2mg /kg on 1st day after 1.6
mg/kg for 4 days
 Quinine di hcl: 20 mg /kg loding
dose…then 10 ml /kg infused iv over 4
hours.
 Chloroquine:(

amodiaquine) acting on
erythrocytic schizontocide against all
species of plasmodia.
 Oral abs is excellent
 Dose: 150mg/day
 ADR: ocular toxicity seen with prolonged
use.
 T1/2 3 to 10 days
 Safe for pregnancy:no abortifacient and no
teratogenic effect.
 Mefloquine:

is relatively fast acting
erythrocytic schizontocides.
 Slower then chloroquine nd quinine
 Orally abs
 Dose: 1.5gm/daily
 T1/2 2-3 week
 Mefloquine appears to be safe during
pregnancy

 Quinine

, quinidine: used for
uncomplicated falciparum malaria
 Dose 15mg/kg for 7 days
 Orally and iv abs
 ADR: cinchonism…
 Cause haemolysis
 Primaquine:pyrimethamine:

radical
treatment of vivax or ovale malaria (
prophylaxis of chloroquine resistant)
 Dose: 15mg/daily for 14 days
 Supra additive synergistic effect wd
sulfonamides antibiotics(dapsone)
 T1/2: 2 to 4 days
 ADR: dose related haemolysis.
 1)

arteether: acute malaria
 Dose 150mg/kg for 3 days
 Given orally, im(complicated)
 T1/2: 23 hours
 2)Artemether: f.malaria
 80mg/daily
 Given by oral iv ,im for every 12 to 24
hours for 5 days
 T1/2: 4 to 5 hr
 Artesunate:
 2.4

falciparum malaria

mg/kg
 Given iv or im for every 12 to 24 hours
 To treat multi drug resistance malaria
 Artesunate-sulfadoxine

 Artesunate

pyrimethamine

mefloquine
 Dihydro artesunate piperaquine…
 Artesunate chlorproguanil dapsone….

Malaria

  • 1.
  • 2.
     Malaria is amosquito-borne infectious disease of humans and other animals caused by parasitic protozoans (a type of unicellular microorganism) of the genus Plasmodium  the disease is transmitted via a bite from an infected female Anopheles mosquito.  which introduces the organisms from its saliva into a person's circulatory system. In the blood.
  • 3.
     Five species ofPlasmodium can infect and be transmitted by humans.  The vast majority of deaths are caused by P. falciparum  P. vivax  P. ovale  P. malariae  P. knowlesi
  • 5.
     The signs andsymptoms of malaria typically begin 8–25 days following infection.  however, symptoms may occur later in those who have taken antimalarial medications as prevention.  Initial manifestations of the disease—common to all malaria species—are similar to flu-like symptoms, and can resemble other conditions such as septicemia, gastroenteritis, and viral diseases.  The presentation may include headache, fever, shivering, joint pain, vomiting, hemolytic anemia, jaundice, hemoglobin in the urine,retinal damage, and convulsions.
  • 6.
     The classic symptom of malaria is paroxysma cyclical occurrence of sudden coldness followed by shivering and then fever and sweating, occurring every two days (tertian fever) in P. vivax and P. ovale infections, and every three days (quartan fever) forP. malariae. P. falciparum infection can cause recurrent fever every 36–48 hours or a less pronounced and almost continuous fever.
  • 7.
    respiratory distress  metabolicacidosis  pulmonary oedema,  anaemia.  , acute respiratory distress syndrome  Infection with P. falciparum may result in cerebral malaria 
  • 9.
    The life cycleof malaria parasites. A mosquito causes infection by taking a blood meal.  First, sporozoites enter the bloodstream, and migrate to the liver.  They infect liver cells, where they multiply into merozoites, rupture the liver cells, and return to the bloodstream.  Then, the merozoites infect red blood cells, where they develop into ring forms, trophozoites and schizonts that in turn produce further merozoites.  Sexual forms are also produced, which, if taken up by a mosquito, will infect the insect and continue the life cycle 
  • 10.
     To prevent andtreat clinical attack of malaria  To completely eradicate the parasite from the patient body  To reduce the human reservoir of infection  Stage of plasmodium in liver called tissue schizontocides…( pre+ exo  - erythcytes.)  stage of plasmodium in blood is called gametocides.
  • 11.
     Chloroquine  Amodiaquine primaquine sulfadoxine artemether halofantrine Piperaquine sulfamethopyrazine  Mefloquine dapsone atovaquone  Quinine,quinidine tetracycline  proguanil, doxycycline  Pyrimathaqunine artesunate
  • 12.
     1)Causal prophylaxis: the preerythrocyticsphase in liver  Proguanil, primaquine.  2)Suppressive prophylaxis: the exoerythrocytics phase in case of vivax and other relapsing malaria continues, clinical disease not appear.  Chloroquine,proguanil,mefloquine,doxy cycline
  • 13.
     3) clinical cure:the erythrocytic, schizontocides are used to terminate an episode of disease.  Fast acitng drug: chloroquine, mefloquine, amodiaquine, quine, halofantrine, atovaquone, artemisinin  Slow acting drug: proguanil,pyrimathamine, sulfonamides, tetracycline.
  • 14.
     4)Radical cure: inthis attack the exoerythrocytic stage( hypnozoites) to achieved total eradication of parasite from patient body. Drug primaquine  Adequate for relapsing malaria.  5) gametocidal: this refer to elimination of the male and female gametes of plasmodia from patient blood (reduce the transmission to mosquito.
  • 15.
     Artesunate: 2.4 mg/kg iv or im after 12 to 24 hour.for 7 days  Artemether: 3.2mg/kg on 1st day…then 1.6 mg/kg daily for 7 days  Arteether: 3.2mg /kg on 1st day after 1.6 mg/kg for 4 days  Quinine di hcl: 20 mg /kg loding dose…then 10 ml /kg infused iv over 4 hours.
  • 16.
     Chloroquine:( amodiaquine) actingon erythrocytic schizontocide against all species of plasmodia.  Oral abs is excellent  Dose: 150mg/day  ADR: ocular toxicity seen with prolonged use.  T1/2 3 to 10 days  Safe for pregnancy:no abortifacient and no teratogenic effect.
  • 17.
     Mefloquine: is relativelyfast acting erythrocytic schizontocides.  Slower then chloroquine nd quinine  Orally abs  Dose: 1.5gm/daily  T1/2 2-3 week  Mefloquine appears to be safe during pregnancy 
  • 18.
     Quinine , quinidine:used for uncomplicated falciparum malaria  Dose 15mg/kg for 7 days  Orally and iv abs  ADR: cinchonism…  Cause haemolysis
  • 19.
     Primaquine:pyrimethamine: radical treatment ofvivax or ovale malaria ( prophylaxis of chloroquine resistant)  Dose: 15mg/daily for 14 days  Supra additive synergistic effect wd sulfonamides antibiotics(dapsone)  T1/2: 2 to 4 days  ADR: dose related haemolysis.
  • 20.
     1) arteether: acutemalaria  Dose 150mg/kg for 3 days  Given orally, im(complicated)  T1/2: 23 hours  2)Artemether: f.malaria  80mg/daily  Given by oral iv ,im for every 12 to 24 hours for 5 days  T1/2: 4 to 5 hr
  • 21.
     Artesunate:  2.4 falciparummalaria mg/kg  Given iv or im for every 12 to 24 hours  To treat multi drug resistance malaria
  • 22.
     Artesunate-sulfadoxine  Artesunate pyrimethamine mefloquine Dihydro artesunate piperaquine…  Artesunate chlorproguanil dapsone….